2002
DOI: 10.1253/circj.66.377
|View full text |Cite
|
Sign up to set email alerts
|

Flecainide Augments Muscle Sympathetic Nerve Activity in Humans.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Antiarrhythmic drugs were discontinued before the procedure and were restarted on the day after the procedure. Prior studies have shown that oral flecainide (47) and intravenous quinidine (38) raised MSNA in healthy individuals, whereas intravenous procainamide (58) decreased MSNA in healthy individuals. To our knowledge, there are no reports regarding the effects of stopping or restarting antiarrhythmic agents on MSNA in patients such as the those we studied.…”
Section: Study Limitationsmentioning
confidence: 99%
“…Antiarrhythmic drugs were discontinued before the procedure and were restarted on the day after the procedure. Prior studies have shown that oral flecainide (47) and intravenous quinidine (38) raised MSNA in healthy individuals, whereas intravenous procainamide (58) decreased MSNA in healthy individuals. To our knowledge, there are no reports regarding the effects of stopping or restarting antiarrhythmic agents on MSNA in patients such as the those we studied.…”
Section: Study Limitationsmentioning
confidence: 99%
“…Fifth, the atrial electophysiologcal properties are affected by sympathetic nerve activity and flecainide augments muscle sympathetic nerve activity. 30 We did not investigate the preventive effect of flecainide. However, the widening of the RAFZ, FAAZ and CDZ is closely related to spontaneously occurring episodes of AF.…”
Section: Study Limitationsmentioning
confidence: 99%